Isoflavone agonists of IRF-3 Dependent signaling have antiviral activity against RNA viruses

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7334-7344

  Bedard, Kristin M ^a   Wang, Myra L ^a   Proll, Sean C ^c   Loo, Yueh Ming ^b   Katze, Michael G ^c   Gale, Michael ^b   Iadonato, Shawn P ^a  

^a Kineta Inc ^*  (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON REGULATORY FACTOR 3; ISOFLAVONE; KIN 100; KIN 101; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; EMBRYO; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLUENZA VIRUS; INNATE IMMUNITY; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RNA VIRUS; SIGNAL TRANSDUCTION;

HEPATITIS C VIRUS; ORTHOMYXOVIRIDAE; RNA VIRUSES;

EID: 84864120309     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06867-11     Document Type: Article

References (33)

1. Andres A, Donovan SM, Kuhlenschmidt MS. 2009. Soy isoflavones and virus infections. J. Nutr. Biochem. 20:563-569.
2. Andres A, Donovan SM, Kuhlenschmidt TB, Kuhlenschmidt MS. 2007. Isoflavones at concentrations present in soy infant formula inhibit rotavirus infection in vitro. J. Nutr. 137:2068 -2073.
3. Barral PM, et al. 2009. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol. Ther. 124: 219-234.
4. Baum A, Sachidanandam R, Garcia-Sastre A. 2010. Preference of RIG-I for short viralRNAmolecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303-16308.
5. Billharz R, et al. 2009. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 83: 10557-10570.
6. Cilloniz C, et al. 2010. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J. Virol. 84:7613-7624.
7. Cushnie TP, Lamb AJ. 2005. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26:343-356.
8. Foy E, et al. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
9. Jiang F, et al. 25 September 2011, posting date. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. 479:423- 427. doi:10.1038/nature10537.
10. Kato H, et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601-1610.
11. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
12. Li E, et al. 2000. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J. Biol. Chem. 275:14729- 14735.
13. Li K, Chen Z, Kato N, Gale M, Jr, Lemon SM. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280:16739 -16747.
14. Lindenbach BD, et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623- 626.
15. Loo YM, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345.
16. Loo YM, and Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692.
17. Loo YM, et al. 2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 103:6001- 6006.
18. Lyu SY, Rhim JY, Park WB. 2005. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch. Pharm. Res. 28:1293-1301.
19. Meylan E, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172.
20. Saito T, et al. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. U. S. A. 104:582-587.
21. Saito T, Owen DM, Jiang F, Marcotrigiano J, and Gale M, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-527.
22. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
23. Stantchev TS, Markovic I, Telford WG, Clouse KA, Broder CC. 2007. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res. 123:178 -189.
24. Sumpter R, Jr, et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689 -2699.
25. Takahasi K, et al. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29:428-440.
26. Tan SL, Ganji G, Paeper B, Proll S, Katze MG. 2007. Systems biology and the host response to viral infection. Nat. Biotechnol. 25:1383-1389.
27. Terenzi F, Hui DJ, Merrick WC, Sen GC. 2006. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281:34064 -34071.
28. Venkataraman T, et al. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444-6455.
29. Wakita T, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
30. Wilkins C, and Gale M, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41- 47.
31. Xu LG, et al. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740.
32. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737.
33. Yura Y, Yoshida H, Sato M. 1993. Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch. Virol. 132:451- 461.